Resultados de búsqueda - Poonam Aggarwal
- Mostrando 1 - 3 Resultados de 3
-
1
-
2
-
3
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial por Diwakar Davar, Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin, F. Amatore, Julie S. Deutsch, Rodrigo X. Das Neves, Richard R. Rodrigues, John A. McCulloch, Hong Wang, Douglas J. Hartman, Jonathan H. Badger, Miriam R. Fernandes, Yulong Bai, Jie Sun, Alicia M. Cole, Poonam Aggarwal, Jennifer R. Fang, Christopher Deitrick, Riyue Bao, Umamaheswar Duvvuri, Shaum Sridharan, Seungwon Kim, Haroon A. Choudry, Matthew P. Holtzman, James F. Pingpank, James Patrick O'Toole, Richelle DeBlasio, Yang Jin, Quanquan Ding, Wentao Gao, Christopher Groetsch, Ornella Pagliano, Amy Rose, Corey Urban, Jagjit Singh, Prajan Divarkar, David Mauro, Dmitri Bobilev, James E. Wooldridge, Arthur Μ. Krieg, Matthew G. Fury, Jeffrey R. Whiteaker, Lei Zhao, Amanda G. Paulovich, Yana G. Najjar, Jason J. Luke, John M. Kirkwood, Janis M. Taube, Hyun Jung Park, Giorgio Trinchieri, Hassane M. Zarour
Publicado 2024Artigo
Herramientas de búsqueda:
Materias Relacionadas
Internal medicine
Medicine
Biology
Endocrinology
Genetics
Placental growth factor
Pregnancy
VEGF receptors
Vascular endothelial growth factor
Breast cancer
CD34
Cancer
Cancer research
Creatinine
Eclampsia
Endoglin
Endothelin 1
Gestation
Gestational age
Immunotherapy
Melanoma
Neoadjuvant therapy
Nivolumab
Obstetrics
Oncology
Preeclampsia
Prospective cohort study
Receptor
Soluble fms-like tyrosine kinase-1
Stem cell